GlaxoSmithKline Financial Analyst Salaries in Boulder | Comparably
"GlaxoSmithKline discovers, develops and manufactures pharmaceuticals, vaccines and consumer healthcare products." read more
EMPLOYEE
PARTICIPANTS
38
TOTAL
RATINGS
380

GlaxoSmithKline Financial Analyst Salaries in Boulder

The average GlaxoSmithKline Financial Analyst in Boulder earns an estimated $78,851 annually, which includes an estimated base salary of $72,518 with a $6,333 bonus. GlaxoSmithKline's Financial Analyst compensation is $8,548 less than the US average for a Financial Analyst. Financial Analyst salaries at GlaxoSmithKline in Boulder can range from $57,500 - $86,000.

In Boulder, The Finance Department at GlaxoSmithKline earns $6,369 more on average than the Operations Department.

Last updated 2 years ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$78,851
Average Compensation
$72,518
avg. base
$6,333
avg. bonus

Financial Analyst Salaries at GlaxoSmithKline

In Boulder, Financial Analysts earn $3,095 more than Financial Analysts, and $2,888 less than Business Analysts.

Accounting Manager
$95k*
Senior Accountant
$94k*
Business Analyst
$82k*
Financial Analyst
$76k*
Accountant
$69k*
* estimated salary

Compensation at GlaxoSmithKline by Department

In Boulder, The Finance Department averages $6,369 more than the Operations Department, and $13,811 less than the Sales Department

Sales
$91,628 Avg. total comp.
+$14k
Finance
$77,817 Avg. total comp.
Operations
$71,448 Avg. total comp.
-$6k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to GlaxoSmithKline reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to GlaxoSmithKline reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.

How Financial Analysts at GlaxoSmithKline Rate Their Compensation

The majority of Financial Analysts at GlaxoSmithKline believe they're compensated fairly. 100% of Financial Analysts at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline

×
Rate your company